UK’s First Real-World Evidence Guideline Targets Randomized Trials

 
• By Vibha Sharma
  
Real world data
Randomized trials using RWD are most likely to be considered for label changes • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Real-World Evidence

More from Clinical Trials